skip to main content

Contact us to get started

Hope begins here.

If you're an HR or benefits professional seeking cancer resources for your employees, or a consultant looking to provide best-in-class cancer support for your clients, share a few details below. We’ll reach out to help your company get started.

If you’re an employee looking for your AccessHope benefit, call 800.423.3232 and select Option 1.

Helping health plans
and insurers to make
a bigger impact

AccessHope closes the cancer knowledge gap with access to renowned NCI expertise

AccessHope connects employees who have been diagnosed with cancer and their community-based oncologists to renowned cancer expertise from National Cancer Institute (NCI)–Designated Comprehensive Cancer Centers to help identify the right treatment early on for the best outcomes possible.

We proudly partner with NCI centers to remotely deliver the latest cancer knowledge to the people and places who need it most.

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute

Read More

Fred Hutch Cancer Center

Fred Hutch Cancer Center

Read More

Johns Hopkins Medicine

Kimmel Cancer Center

Read More

Northwestern Medicine

Northwestern Medicine

Read More

UT Southwestern Medical Center

Harold C. Simmons Comprehensive Cancer Center

Read More
Physicians-final

Supporting Members

Members can request a full case review for any cancer type, providing peace of mind that their treatment plan with their community oncologist is on the right path. Members and their families also gain access to compassionate nurses who can offer information and empowerment whenever they need it. This commitment to overall support has earned this service a world-class net promoter score of 90.

Members-final

Supporting Plans

AccessHope’s algorithms work in collaboration with the member’s health plan to securely send certain cancer cases to our subspecialists, who can offer advice to that plan that the treating oncologist can reference — without any action required by the member. 

Our AccessHope team is very flexible, innovative, and solution-oriented. They bring forth expertise and thought-provoking conversations that drive high-end outcomes needed to support health equity and wrap-around services for cancer care.

The AccessHope team is a true partner. They care about what we care about and always try to help us resolve even some of the most challenging asks. Most importantly, they listen and make us feel valued as a client. We are always reaching higher and for more, and they are along for the ride. Together, we are making a difference.

The proof is in the
(peer-reviewed) paper

Our subspecialists provided evidence-based recommendations that had the potential to influence the treatment plan in approximately 93% of cases.1

Download the study summary

+-

How do community oncologists react to the doctor-to-doctor conversations?

Community oncologists who participated in clinical consultation calls (CCCs) with an AccessHope expert responded positively and are appreciative of our recommendations: small studies have concluded that there is high adoption, and treating oncologists are implementing some or all of our recommendations.

+-

How does AccessHope work in practice? What exactly do you do?

AccessHope connects members to expertise from NCI–Designated Comprehensive Cancer Centers—to provide unparalleled decision support to cancer patients’ treating physicians and health plans throughout the cancer journey.

Learn more about our suite of services.

+-

How do you handle member privacy?

AccessHope values members’ privacy. All employee information is transmitted, used and stored securely, according to applicable HIPAA guidelines.

+-

How do you provide expertise to members with cancer? Do they need to travel?

AccessHope services do not require members to travel, but instead provide remote access to leading-edge insights.

References:

1 West HJ, Tan YA, Barzi A, Wong D, Parsley R, Sachs T. Novel program offering remote, asynchronous subspecialist input in thoracic oncology: Early experience and insights gained during the COVID-19 pandemic [published online ahead of print December 3, 2021]. JCO Oncology Practice. doi:10.1200/OP.21.00339